• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

向量自回归:在罕见疾病中有帮助吗?-预测继发 AA 淀粉样变性罕见病例中的器官反应模式。

Vector autoregression: Useful in rare diseases?-Predicting organ response patterns in a rare case of secondary AA amyloidosis.

机构信息

Interdisciplinary Amyloidosis Center of Northern Bavaria, University and University Hospital Würzburg, Würzburg, Germany.

Department of Internal Medicine II, Hematology, University Hospital Würzburg, Würzburg, Germany.

出版信息

PLoS One. 2023 Aug 10;18(8):e0289921. doi: 10.1371/journal.pone.0289921. eCollection 2023.

DOI:10.1371/journal.pone.0289921
PMID:37561769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10414553/
Abstract

BACKGROUND

Statistical analyses of clinical data are a cornerstone in understanding pathomechanisms of disorders. In rare disorders, cross-sectional datasets of sufficient size are usually not available. Taking AA amyloidosis as an example of a life-threatening rare disorder resulting from of uncontrolled chronic inflammation, we propose techniques from time series analysis to predict organ response to treatment. The advantage of time-series analysis is that it solely relies on temporal variation and therefore allows analyzing organ response to treatment even when the cross-sectional dimension is small.

METHODS

The joint temporal interdependence of inflammatory activity and organ response was modelled multivariately using vector autoregression (VAR) based on a unique 4.5 year spanning data set of routine laboratory, imaging data (e.g., 18F-Florbetaben-PET/CT) and functional investigations of a 68-year-old patient with multi-organ involvement of AA amyloidosis due to ongoing inflammatory activity of a malignant paraganglioma in stable disease for >20 years and excellent response to tocilizumab).

RESULTS

VAR analysis showed that alterations in inflammatory activity forecasted alkaline phosphatase (AP). AP levels, but not inflammatory activity at the previous measurement time point predicted proteinuria.

CONCLUSION

We demonstrate the feasibility and value of time series analysis for obtaining clinically reliable information when the rarity of a disease prevents conventional prognostic modelling approaches. We illustrate the comparative utility of blood, functional and imaging markers to monitor the development and regression of AA amyloidosis.

摘要

背景

对临床数据进行统计学分析是理解疾病发病机制的基石。在罕见疾病中,通常无法获得足够大的横断面数据集。以 AA 淀粉样变性为例,这是一种由不受控制的慢性炎症引起的危及生命的罕见疾病,我们提出了时间序列分析技术来预测器官对治疗的反应。时间序列分析的优势在于它仅依赖于时间变化,因此即使在横断面维度较小的情况下,也可以分析器官对治疗的反应。

方法

采用基于向量自回归(VAR)的多变量模型,对炎症活动和器官反应的联合时间相关性进行建模。该模型基于一名 68 岁患者的独特 4.5 年跨度的数据集,该患者患有多器官 AA 淀粉样变性,由于恶性副神经节瘤的持续炎症活动,处于稳定疾病状态超过 20 年,对托珠单抗治疗反应良好。

结果

VAR 分析表明,炎症活动的变化预测碱性磷酸酶(AP)。AP 水平,而不是前一次测量时间点的炎症活动,预测蛋白尿。

结论

我们证明了时间序列分析在疾病罕见性阻止常规预后建模方法时获取临床可靠信息的可行性和价值。我们说明了血液、功能和成像标志物在监测 AA 淀粉样变性的发展和消退方面的比较效用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1505/10414553/94ffbc77aa10/pone.0289921.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1505/10414553/49adb04939b9/pone.0289921.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1505/10414553/0a1bb28237d9/pone.0289921.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1505/10414553/75f411e2490c/pone.0289921.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1505/10414553/94ffbc77aa10/pone.0289921.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1505/10414553/49adb04939b9/pone.0289921.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1505/10414553/0a1bb28237d9/pone.0289921.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1505/10414553/75f411e2490c/pone.0289921.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1505/10414553/94ffbc77aa10/pone.0289921.g004.jpg

相似文献

1
Vector autoregression: Useful in rare diseases?-Predicting organ response patterns in a rare case of secondary AA amyloidosis.向量自回归:在罕见疾病中有帮助吗?-预测继发 AA 淀粉样变性罕见病例中的器官反应模式。
PLoS One. 2023 Aug 10;18(8):e0289921. doi: 10.1371/journal.pone.0289921. eCollection 2023.
2
Clinical Utility of 18F-Florbetaben PET for Detecting Amyloidosis Associated With Multiple Myeloma: A Prospective Case-Control Study.18F-氟脱氧葡萄糖 PET 检测多发性骨髓瘤相关淀粉样变性的临床效用:一项前瞻性病例对照研究。
Clin Nucl Med. 2019 Sep;44(9):e503-e509. doi: 10.1097/RLU.0000000000002699.
3
Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.托珠单抗对白介素-6的治疗性阻断在AA型淀粉样变性和慢性炎症性疾病管理中的应用:病例系列及文献综述
Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S46-53. Epub 2015 Jun 29.
4
Detection of cardiac amyloidosis with F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy.氟[18F]氟代脱氧葡萄糖-PET/CT 与超声心动图、心脏 MRI 和 DPD 闪烁显像比较检测心脏淀粉样变性。
Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1407-1416. doi: 10.1007/s00259-019-04290-y. Epub 2019 Feb 23.
5
AA amyloidosis in inflammatory active malignant paraganglioma.炎症活跃性恶性副神经节瘤中的AA型淀粉样变性
Amyloid. 2022 Jun;29(2):137-138. doi: 10.1080/13506129.2021.2016691. Epub 2022 Feb 2.
6
Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.托珠单抗在组织学上改善了一名多中心Castleman病患者的AA型肾淀粉样变性:病例报告
Clin Nephrol. 2018 Sep;90(3):232-236. doi: 10.5414/CN109273.
7
Blockade of interleukin-6 as a possible therapeutic target for AA amyloidosis.阻断白细胞介素-6 可能成为淀粉样变性 AA 治疗的靶点。
Nefrologia (Engl Ed). 2022 Jan-Feb;42(1):28-32. doi: 10.1016/j.nefroe.2022.02.003. Epub 2022 Feb 16.
8
Isolated Lymph Node Amyloidosis: Response Assessment to Chemotherapy on Serial 18F-FDG PET/CT Scans.孤立性淋巴结淀粉样变性:连续 18F-FDG PET/CT 扫描评估化疗反应。
Clin Nucl Med. 2020 Sep;45(9):705-706. doi: 10.1097/RLU.0000000000003156.
9
A rare cause of AA amyloidosis: Glomus tumor and treatment with anakinra-Case report and literature review.一种罕见的淀粉样变性病(AA 型)病因:血管球瘤,并用阿那白滞素进行治疗——病例报告和文献复习。
Int J Rheum Dis. 2024 Jan;27(1):e14984. doi: 10.1111/1756-185X.14984. Epub 2023 Nov 28.
10
Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body F-Florbetapir PET/CT.全身 F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描术早期检测多器官轻链淀粉样变性。
J Nucl Med. 2019 Sep;60(9):1234-1239. doi: 10.2967/jnumed.118.221770. Epub 2019 Apr 6.

本文引用的文献

1
AA amyloidosis in inflammatory active malignant paraganglioma.炎症活跃性恶性副神经节瘤中的AA型淀粉样变性
Amyloid. 2022 Jun;29(2):137-138. doi: 10.1080/13506129.2021.2016691. Epub 2022 Feb 2.
2
Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy.关于转甲状腺素蛋白淀粉样心肌病监测的专家共识。
Eur J Heart Fail. 2021 Jun;23(6):895-905. doi: 10.1002/ejhf.2198. Epub 2021 May 24.
3
Amyloidosis-the Diagnosis and Treatment of an Underdiagnosed Disease.淀粉样变性——一种被低估的疾病的诊断与治疗。
Dtsch Arztebl Int. 2020 Mar 6;117(10):159-166. doi: 10.3238/arztebl.2020.0159.
4
Amyloidosis in Heart Failure.心力衰竭中的淀粉样变性
Curr Heart Fail Rep. 2019 Dec;16(6):285-303. doi: 10.1007/s11897-019-00446-x.
5
Detection of cardiac amyloidosis with F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy.氟[18F]氟代脱氧葡萄糖-PET/CT 与超声心动图、心脏 MRI 和 DPD 闪烁显像比较检测心脏淀粉样变性。
Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1407-1416. doi: 10.1007/s00259-019-04290-y. Epub 2019 Feb 23.
6
Validation of Mayo Clinic Staging System for Light Chain Amyloidosis With High-Sensitivity Troponin.基于高敏肌钙蛋白的梅奥诊所轻链淀粉样变性分期系统的验证
J Clin Oncol. 2019 Jan 10;37(2):171-173. doi: 10.1200/JCO.18.01398. Epub 2018 Nov 15.
7
Secondary, AA, Amyloidosis.继发性AA型淀粉样变性
Rheum Dis Clin North Am. 2018 Nov;44(4):585-603. doi: 10.1016/j.rdc.2018.06.004. Epub 2018 Sep 7.
8
Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria.AL 淀粉样变性中器官反应的深度与改善的生存相关:器官反应标准的分级。
Leukemia. 2018 Oct;32(10):2240-2249. doi: 10.1038/s41375-018-0060-x. Epub 2018 Feb 20.
9
Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis.重复给予针对血清淀粉样蛋白 P 成分的抗体可清除系统性淀粉样变性患者的淀粉样沉积物。
Sci Transl Med. 2018 Jan 3;10(422). doi: 10.1126/scitranslmed.aan3128.
10
A new staging system for cardiac transthyretin amyloidosis.心脏转甲状腺素蛋白淀粉样变性的新分期系统。
Eur Heart J. 2018 Aug 7;39(30):2799-2806. doi: 10.1093/eurheartj/ehx589.